PatentTitleOwnerPriorityFiled DateIssue Date
US9995706Amperometric gas sensorSteris Corporation25- Jun- 1230- Sep -1412- Jun- 18
US9995705Amperometric gas sensorSteris Corporation25- Jun- 1230- Sep -1412- Jun- 18
US9994558Multicyclic compounds and methods of using sameKaryopharm Therapeutics Inc.20- Sep- 1319- Sep -1412- Jun- 18
US9994550Heterocyclic modulators of lipid synthesis for use against cancer and viral infections3-V Biosciences, Inc.7- Jan- 147- Jan -1512- Jun- 18
US9993543Immunogenic compositions comprising silicified virus and methods of usePortland State University31- Jan- 1331- Jan -1412- Jun- 18
US9982257Chiral controlWAVE LIFE SCIENCES LTD.13- Jul-1212- Jul- 1329- May -18
US9982241Recombinant HCMV and RHCMV vectors and uses thereofOregon Health & Science University14- May- 101- Oct -1529- May -18
US9982025Monomeric griffithsin tandemersThe United States of America, as represented by the Secretary, Department of Health and Human Services5- Jun- 135- Jun -1429- May -18
US9981036Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the sameTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA12- Dec- 1126- Feb -1629- May -18
US9975885Broad-spectrum non-covalent coronavirus protease inhibitorsPURDUE RESEARCH FOUNDATION28- Apr- 1628- Apr -1722- May -18
US9974850Immunogenic compositions and uses thereofBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM25- Mar- 1525- Mar -1622- May -18
US9974848Tetanus toxoid and CCL3 improve DC vaccinesDuke University14- Nov- 1314- Nov -1422- May -18
US9974845Combination of vaccination and inhibition of the PD-1 pathwayCureVac AG22- Feb- 1321- Feb -1422- May -18
US9970061Bioagent detection oligonucleotidesIBIS BIOSCIENCES, INC.27- Dec- 1127- Dec -1215- May -18
US9969793Compositions and methods for the treatment of immunodeficiencyADMA Biologics, Inc.28- Oct- 1413- Nov -1715- May -18
US9963718LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus- producing cells for the therapy of tumorsVIRATHERAPEUTICS GMBH8- Oct- 087- Apr -178- May -18
US9963611Composition for use in decreasing the transmission of human pathogensInnonix Technologies, Incorporated29- May- 0921- May -108- May -18
US9963427Dithiol mucolytic agentsPARION SCIENCES, INC.23- Aug- 1311- Mar -168- May -18
US9962439Injectable vaccine compositionNITTO DENKO CORPORATION3- Oct- 132- Oct -148- May -18
US9957302Treating cancer with viral nucleic acidMayo Foundation for Medical Education and Research20- Feb- 076- Jul- 151- May -18
US9957300Virus-like particles, methods of preparation, and immunogenic compositionsEmory University17- May- 024- May -151- May -18
US9957238Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compoundsParion Sciences, Inc.13- Dec- 131- Mar -171- May -18
US9951317Highly efficient influenza matrix (M1) proteinsNOVAVAX, INC.11- Jul-036- Oct -1624- Apr- 18